ADAR1 Capital Management, LLC - Significant Ownership

Signature - Title
Stephen Scipione - Chief Compliance Officer
Location
Austin, TX
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by ADAR1 Capital Management, LLC.

Significant Ownership of ADAR1 Capital Management, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
KROS Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share 13.29% $54.9M 5.39M ADAR1 Capital Management, LLC Apr 4, 2025
IKT Inhibikase Therapeutics, Inc. Common Stock, $0.001 par value 9.99% $16.6M 6.99M ADAR1 Capital Management GP, LLC Dec 31, 2024
IBIO iBio, Inc. Common Stock, par value $0.001 per share 9.99% $4.38M 1.1M ADAR1 Capital Management, LLC Dec 31, 2024
KALA KALA BIO, Inc. Common Stock, par value $0.001 per share 4.91% $2.02M 299K ADAR1 Capital Management, LLC Dec 31, 2024
ZURA ZURA BIO LIMITED Class A Ordinary Shares, par value $0.0001 per share 3.18% $2.67M 2.08M ADAR1 Capital Management, LLC Dec 31, 2024

Schedules 13D/G Reported by ADAR1 Capital Management, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.